Could a simple vaccine cut infant deaths? trial investigates

NCT ID NCT02504203

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at whether giving the BCG vaccine (normally given later) right after birth could reduce deaths in babies under 2 months old. Over 2,300 newborns in rural and urban areas took part. The trial was stopped early, so we don't have final answers yet.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

BCG vaccine (Bacillus Calmette-Guérin)

What this could lead to

If it works, giving BCG earlier could save many newborn lives in areas with high infant mortality.

What could go wrong

The trial was terminated early, so results are limited. The effect may vary by setting and not be as strong as hoped.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INFANT MORTALITY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Infant Death

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Bandim Health Project

    Bissau, Guinea-Bissau